1. Home
  2. TRUP vs SRPT Comparison

TRUP vs SRPT Comparison

Compare TRUP & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRUP
  • SRPT
  • Stock Information
  • Founded
  • TRUP 2000
  • SRPT 1980
  • Country
  • TRUP United States
  • SRPT United States
  • Employees
  • TRUP N/A
  • SRPT N/A
  • Industry
  • TRUP Medical Specialities
  • SRPT Biotechnology: Pharmaceutical Preparations
  • Sector
  • TRUP Health Care
  • SRPT Health Care
  • Exchange
  • TRUP Nasdaq
  • SRPT Nasdaq
  • Market Cap
  • TRUP 1.9B
  • SRPT 2.0B
  • IPO Year
  • TRUP 2014
  • SRPT 1997
  • Fundamental
  • Price
  • TRUP $44.47
  • SRPT $18.10
  • Analyst Decision
  • TRUP Buy
  • SRPT Hold
  • Analyst Count
  • TRUP 5
  • SRPT 31
  • Target Price
  • TRUP $55.60
  • SRPT $40.61
  • AVG Volume (30 Days)
  • TRUP 422.1K
  • SRPT 7.8M
  • Earning Date
  • TRUP 10-29-2025
  • SRPT 11-05-2025
  • Dividend Yield
  • TRUP N/A
  • SRPT N/A
  • EPS Growth
  • TRUP N/A
  • SRPT N/A
  • EPS
  • TRUP 0.25
  • SRPT N/A
  • Revenue
  • TRUP $1,360,295,000.00
  • SRPT $2,481,531,000.00
  • Revenue This Year
  • TRUP $12.62
  • SRPT $10.78
  • Revenue Next Year
  • TRUP $6.70
  • SRPT N/A
  • P/E Ratio
  • TRUP $175.99
  • SRPT N/A
  • Revenue Growth
  • TRUP 13.11
  • SRPT 64.89
  • 52 Week Low
  • TRUP $31.00
  • SRPT $10.42
  • 52 Week High
  • TRUP $57.90
  • SRPT $138.81
  • Technical
  • Relative Strength Index (RSI)
  • TRUP 41.22
  • SRPT 51.18
  • Support Level
  • TRUP $42.96
  • SRPT N/A
  • Resistance Level
  • TRUP $45.11
  • SRPT $18.21
  • Average True Range (ATR)
  • TRUP 1.19
  • SRPT 0.88
  • MACD
  • TRUP 0.07
  • SRPT -0.71
  • Stochastic Oscillator
  • TRUP 49.00
  • SRPT 92.30

About TRUP Trupanion Inc.

Trupanion Inc is a specialty insurance products provider in the United States. Its core business is the sale of insurance products tailor-made for pets, especially cats and dogs. It operates in two business segments: The subscription business segment generates revenue majorly from subscription fees related to the Company's direct-to-consumer products and Other business segment is comprised of revenue from other product offerings that generally have a business-to-business relationship and a different margin profile than subscription business segment, including revenue from writing policies on behalf of third parties and revenue from other products and software solutions.

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.

Share on Social Networks: